By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Pepiniere Sante Cochin
29 rue du Faubourg Saint Jacques
Paris    75014  France
Phone: 01-55-426200 Fax: 01-55-426201


Company News
PHARNEXT Announces That The Data Safety Monitoring Boardrecommends Continuing The Ongoing Phase 3 Trial Of PXT3003 For Charcot-Marie-Tooth Disease Type 1A 11/17/2016 11:35:26 AM
PHARNEXT Announces Support Of The First Patient-Centered Charcot-Marie-Tooth Summit Organized By The Hereditary Neuropathy Foundation 10/4/2016 12:30:46 PM
PHARNEXT Confirms Its Continuous Support Of The Hereditary Neuropathy Foundation To Increase Global Awareness Of Charcot-Marie-Tooth Disease 9/15/2016 11:39:01 AM
PHARNEXT’s PXT3003 Featured In Multiple Presentations At The 6th International Charcot-Marie-Tooth And Related Neuropathy Consortium (CMTR) Meeting 9/1/2016 11:25:56 AM
PHARNEXT Announces The Appointment Of René Goedkoop As Chief Medical Officer And François Chamoun As General Counsel 7/26/2016 11:03:22 AM
PHARNEXT Announces The Successful Completion Of Its IPO Raising €31 Million On The Euronext Alternext Stock Exchange In Paris 7/15/2016 10:19:37 AM
PHARNEXT Announces The Nomination Of A New Board Of Directors Chaired By Michel De Rosen 6/1/2016 7:36:09 AM
PHARNEXT Announces The Opening Of The First U.S. Study Site For Its PLEO-CMT International Pivotal Phase 3 Trial In Charcot-Marie-Tooth Disease Type 1A 4/25/2016 6:03:47 AM
PHARNEXT Announces The Appointment Of Niall Murphy As Chief Scientific Officer And Pierre Schwich As Chief Financial Officer 2/22/2016 7:52:39 AM
PHARNEXT Supports The Fight Against Rare Diseases Through Development Of Pleotherapy-Based Treatments 2/16/2016 10:40:21 AM